CSL Behring is committed to helping improve the quality of life for people with rare and serious diseases worldwide. This commitment is reflected in our support of programmes and activities for patients with rare plasma-protein related diseases, including bleeding disorders and primary immune deficiencies.

We collaborate with patient advocacy platforms, both disease-specific and umbrella organisations, to promote quality medical care and services and to improve and expand educational and outreach efforts. Through these partnerships, we strive to raise public awareness and to enhance appropriate public policies for rare diseases.

We support Genetic Alliance UK and Rare Disease UK, which provide a united voice for the rare disease community by capturing the experiences of patients and families. It work with supporters to raise the profile of rare diseases across the UK and seeks to bring about lasting change offering better health and quality of life for individuals and families affected by rare diseases.